PreViser Corporation Appoints Director of Medical Technology to Expand Further Into Medicine
Posted on: Wednesday, 16 July 2008, 06:00 CDT
MOUNT VERNON, Wash., July 16 /PRNewswire/ -- PreViser Corporation, a leader in oral health risk assessment and management, announced that Dr. Randy R. Nolf, DDS has been appointed as their new Director of Medical Technology. PreViser (http://www.previser.com/) has the only patented, research-validated software that allows all dental professionals to accurately analyze patients' current oral health and future risk of oral diseases or problems. The program creates graphical reports that aid in treatment planning and enable patients to more fully participate in their treatment decisions by making their risk and disease status understandable. The PreViser suite of assessment tools has been translated into 4 languages and is accessed by dentists in over 40 countries.
*(LOGO 72dpi: Send2Press.com/mediaboom/08-0520-PreViser_72dpi.jpg)
PreViser is expanding this same risk assessment analysis into numerous fields of medical science, creating technology that provides decision support for medical professionals and education for patients to increase participation and compliance in their own treatments. Risk identification and management of disease in the earliest stage is sound cost saving strategy -- increasingly important as patients must accept a larger share of their healthcare expenditures. When asked about PreViser's advance into medicine, Dr. Nolf stated, "We're applying important lessons learned from dentists and in dental disease management to other systemic diseases and other types of practice."
Dr. Nolf was one of the 10 periodontists on the original concept development team leading to PreViser's technology and co-holds the patent. He has maintained a full-time Periodontology practice in Stroudsburg, Pennsylvania while playing an advisory role with PreViser. "Dr. Nolf's innovative and continuing contributions to the field of disease management through computerized, objective risk and disease analysis makes it a logical progression to appoint him as the Director of Medical Technology as we expand beyond dentistry into other disease entities," stated Carl Loeb, PreViser CEO.
Nolf graduated from Temple University School of Dentistry in 1979, did his post-doctoral specialty training in the Temple Graduate Periodontology Program 1979-1981, and was a Clinical Surgical Instructor 1990-1999 in the Temple Graduate Perio Program. In his own practice, he shows a strong interest in software and technology, and is an active member of many dental associations.
When asked about the future of his practice Nolf said, "These are exciting times -- medicine and dentistry are changing, and the next revolution will be in technology for less costly, interceptive treatments before expensive repair is required. Utilizing the same amount of money to treat a growing population while improving the outcomes for our patients is possible and confirmed by research. It's a great advantage to be in full-time practice while engaged in the development of these new technologies; it brings unique perspective to both my practice and my contribution at PreViser."
Nolf will continue his practice full-time with limited speaking engagements. For more information or an interview, contact Dr. Nolf through his Stroudsburg office 570-420-1500.
More information about PreViser technology: http://www.previser.com/.
This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.send2press.com/
PreViser Corporation
CONTACT: Mikyn Sygitowicz of PreViser Corporation, 1-888-854-0007,ext. 9, info@previser.com
Web site: http://www.previser.com/http://www.send2press.com/
Source: PRNewswire
Related Articles
- Management Strategies For High Risk Stroke Patients Are Poor In A Majority Of Cases
- 'Delivering Disease Management to Medically Underserved Populations' Report Will Help You Begin Implementing Program Success With Community Agency and Provider Partnerships
- Janus Health Introduces JanusOS(SM): First Technology-Enabled Mobile Patient Management Solution to Support Physician Housecalls
- Philips Announces U.S. Commercial Launch of Motiva - a TV-Based Platform for Remote Patient Management; Motiva Uses the Home TV to Actively Engage Chronic Disease Patients With Personalized Healthcare Content As Part of Their Daily Routines
- Aspirin Useful in Reducing Stroke Risk of Patients With Establishedheart Disease: Study
- Survey: Consumers Believe Chronic Disease Patients to Be Medically Underserved
- New Study Data in December 9th New England Journal of Medicine Shows Medication May Help Parkinson's Disease Patients With Dementia
- Pretransplant Psychiatric and Medical Comorbidity of Alcoholic Liver Disease Patients Who Received Liver Transplant
- Lowering BP With Medication Provides Unexpected Benefits for Heart Disease Patients With 'Normal' Blood Pressure
- Amgen Launches Landmark Trial to Evaluate the Impact of Treating Anemia on Cardiovascular Risks in Patients With Chronic Kidney Disease and Type 2 Diabetes
User Comments (0)

RSS Feeds